|
Market Closed -
Toronto S.E.
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 18.50 CAD | -0.32% |
|
+3.47% | +15.12% |
| 09-28 | DRI Healthcare Trust Comments on FDA Approval of Juvmo for Treatment of Motor Symptoms that Occur in Parkinson's Disease | CI |
| 09-21 | DRI Healthcare Trust - Special Call |
| Market Cap | 727M 649M 600M 544M 1.02B 69.01B 1.03B 7.22B 2.86B 36.16B 2.73B 2.67B 114B | P/E 2026 * |
22.1x | P/E 2027 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.27B 1.13B 1.05B 948M 1.77B 120B 1.8B 12.59B 4.98B 63.07B 4.76B 4.66B 199B | EV / Sales 2026 * |
6.53x | EV / Sales 2027 * | 5.23x |
| Free-Float |
99.76% | Yield 2026 * |
3.25% | Yield 2027 * | 3.42% |
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| DHT.U | Delayed | |
OTC Markets
| DHTRF | Delayed | |
|
Toronto S.E.
| DHT.U | Delayed | |
|
Deutsche Boerse AG
| 3IJ0 | Delayed |
Last Transcript: DRI Healthcare Trust
| 1 day | -0.32% | ||
| 1 week | +3.47% | ||
| Current month | +1.04% | ||
| 1 month | +0.71% | ||
| 3 months | +5.96% | ||
| 6 months | +12.05% | ||
| Current year | +15.12% |
| 1 week | 17.91 |  | 18.67 |
| 1 month | 17.83 | | 18.9 |
| Current year | 15 | | 19.75 |
| 1 year | 14.77 | | 19.75 |
| 3 years | 10.39 | | 19.75 |
| 5 years | 5.83 | | 19.75 |
| 10 years | 5.83 | | 19.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ali Hedayat
CEO | Chief Executive Officer | 51 | 2020-05-31 |
Zaheed Mawani
DFI | Director of Finance/CFO | - | 2025-09-30 |
| Chief Tech/Sci/R&D Officer | - | 2014-08-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Gary Collins
CHM | Chairman | 63 | 2021-01-21 |
Ali Hedayat
BRD | Director/Board Member | 51 | 2020-05-31 |
Kevin Layden
BRD | Director/Board Member | 66 | 2021-01-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 9/1/26 | Option | Chairman | -3,008 | 0.0055% | ||
| 9/1/26 | Option | Chairman | 1,397 | 0.0025% | ||
| 9/1/26 | Option | Chairman | 1,397 | 0.0025% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.32% | +3.47% | +22.11% | +71.61% | 727M | |
| -2.54% | +1.31% | +54.27% | +114.96% | 1,135B | |
| -1.42% | +3.23% | +38.56% | +74.44% | 635B | |
| +0.16% | +0.08% | +25.29% | +95.23% | 505B | |
| -0.31% | +3.09% | +44.14% | +64.80% | 378B | |
| -1.34% | -0.47% | +66.04% | +41.00% | 358B | |
| -0.68% | +2.65% | +22.98% | +50.39% | 295B | |
| -1.20% | +3.04% | +2.33% | +22.86% | 266B | |
| -1.79% | +1.57% | +50.56% | +59.08% | 237B | |
| -0.73% | -0.10% | +29.02% | +99.67% | 193B | |
| Average | -1.02% | +2.30% | +35.53% | +69.40% | 400.44B | |
| Weighted average by Cap. | -1.35% | +2.66% | +41.02% | +79.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 194M 173M 160M 145M 272M 18.43B 276M 1.93B 763M 9.65B 729M 713M 30.44B | 225M 201M 186M 168M 315M 21.38B 320M 2.24B 885M 11.2B 845M 827M 35.32B |
| Net income | 30.3M 27.05M 24.99M 22.65M 42.37M 2.88B 43.07M 301M 119M 1.51B 114M 111M 4.75B | 27.05M 24.16M 22.32M 20.22M 37.83M 2.57B 38.46M 269M 106M 1.35B 102M 99.36M 4.24B |
| Net Debt | 541M 483M 446M 404M 757M 51.36B 769M 5.37B 2.13B 26.91B 2.03B 1.99B 84.83B | 452M 403M 372M 338M 631M 42.86B 642M 4.48B 1.77B 22.46B 1.69B 1.66B 70.8B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | $18.50 | -0.32% | 22,920 |
| 26-10-22 | $18.56 | +0.43% | 17,201 |
| 26-10-21 | $18.48 | -0.38% | 5,414 |
| 26-10-20 | $18.55 | +1.20% | 29,600 |
| 26-10-19 | $18.33 | +2.52% | 32,786 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DHT.U Stock
Select your edition
All financial news and data tailored to specific country editions
